News Archives - neuroCare

1300 149 300info@neurocareclinics.com.au Referral Form for DoctorsClick here to download neurocaregroup.comSee what we do globally

Call 1300 149 300
or write to us

The Conversation

September 26, 2018

A study at the University of Southern California has investigated the link between digital media use and the development of ADHD-related behaviours among 15- and 16-year-olds. This study highlights a potential association between digital media and behavioural symptoms typically associated with ADHD.

neuroCare Group

September 18, 2018

neuroCare has established a global network of clinics and training centres, now in Australia, for professionals interested in EEG Biofeedback and Neurostimulation techniques, proven to have beneficial and sustainable effects in mental health.

neuroCare Group

July 1, 2018

New study shows brain activity measured by QEEG can help predict which children may or may not respond to medications for ADHD

neuroCare Group

February 19, 2018

Researchers compare methods of treating ADHD in children and find that Neurofeedback, a medication-free technique, has long-lasting effects, according to a recent study published in the medical journal European Child & Adolescent Psychiatry.

neuroCare Group

February 6, 2018

Researchers find cost of rTMS treatment to be more cost-effective as compared to antidepressant medication trials, factoring in financial commitment and quality of life post treatment.

neuroCare Group

November 15, 2017

New study shows that magnetic brain stimulation (TMS) combined with concurrent psychotherapy is more effective than either technique alone with 66% of research subjects with Depression responding well in an average of 21 session. 65% of the group achieved long-term benefit.

neuroCare Group

October 26, 2017

Members of the Royal Australian and New Zealand College of Psychiatry are putting forward a new submission to have TMS subsidized under Australia’s public health fund, Medicare.

neuroCare Group

September 21, 2017

neuroCare’s brand of evidence-based and sustainable therapies for ADHD, Depression & OCD, is now available in Melbourne as the company joins with the Listen And Learn Centre in Balwyn.

neuroCare Group

August 30, 2017

neuroCare was the proud sponsor of the ADHD Heroes team for the 2017 City2Surf event in Sydney, entered by ‘ADDults with ADHD,’ a charity dedicated to improving the lives of adults and families dealing with ADHD.

neuroCare Group

March 15, 2017

A study by neuroCare's researchers in The Netherlands has looked at the effects of TMS on patients with treatment resistant OCD, finding that 55% of patients responded to treatment and were more likely to respond if they had also addressed a sleep issue.

Personalising Mental Healthcare since 2001, using state-of-the-art neuromodulation to help children, adults and their families achieve lasting mental wellness.

www.neurocaregroup.com

Latest News and Science

Research Check: are phone-obsessed teens at greater risk of ADHD?

Professional Neuromodulation Training in Sydney – New Workshops Announced for 2019

Brain activity predicts response to medication in ADHD

New Study Confirms Neurofeedback has long-term benefit for Children with ADHD

TMS more cost-effective treatment for major depressive disorder, study finds

Combined TMS and Psychotherapy more effective treatment for Depression

Australian Psychiatrists push for TMS to be subsidised

neuroCare opens new clinic in Melbourne, joining with Listen And Learn centre

‘ADHD Heroes’ conquer Sydney’s famous City2Surf run

Treating OCD with TMS: Sleep could play a key role in treatment outcome

How Did You Get Interested in the Field of Neuromodulation? Conversations with Dr Martijn Arns, Neuromodulation Expert

What is Neurofeedback? Clarifying misconceptions of an evidence-based brain training technique

Why our Psychologists and Psychiatrists are big on addressing sleep in mental health

Treatment Areas

Helpful Links